Navigation Links
ZyStor to exhibit cell disorder treatments

Milwaukee, Wis. - Loren Peterson, president and CEO of ZyStor Therapeutics, Inc. is looking forward to showcasing his Milwaukee company for attendees of this year's Midwestern bioscience forum.

As a presenter at the conference, Peterson will represent Wisconsin biotechnology companies with another presenter, Dr. Irene Hrusovsky, CEO of Madison-b......

Full article >>> estimated to affect 1 in 7,700 live births.

"Our intellectual property surrounds a way of attaching a peptide tag to these enzymes - to better target receptors on cell surfaces on clinically significant tissues - so that it can get into the lysosome of the cell, where it can then reduce the storage material that builds up in patients," Peterson explained.

ZyStor is in preclinica......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 09/12/06


Related biology technology :

1. ZyStor seeks to raise $15M for clinical trials
2. Milwaukee area biotech ZyStor seeks more funding
3. ZyStor receives first funding and buys theraputics for rare diseases
4. Engineers help turn science into interactive exhibits
5. Nanotech exhibit opens at UW-Madison
6. Gender hormones may lend to social disorder therapies
7. TomoTherapy leads the industry in CT image-guided treatments
8. Medical College getting $18.1 million to study radiation damage treatments
9. Research on fruit flies opens up possibilities for human treatments
10. UW discovery could lead to new TB treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... 2017   Biostage, Inc. (Nasdaq: ... developing bioengineered organ implants to treat cancers and other ... today the closing on February 15, 2017 of its ... stock and warrants to purchase 20,000,000 shares of common ... offering was priced at $0.40 per share of common ...
(Date:2/16/2017)... , Feb. 16, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... Series 1a financing and entered into a $5 ...  Dermata intends to use the capital for general ... major advancements in the treatment of serious diseases ...
(Date:2/16/2017)... Pa. , Feb. 16, 2017  Windtree ... biotechnology company focusing on developing aerosolized KL4 surfactant ... from a preclinical influenza study showed that aerosolized ... survival in a well-established preclinical animal model. The ... a growing body of evidence that supports the ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... extended its industry leading Biochemistry Services specifically targeting the rapidly growing needs ... methods for the biochemical and biosimilar characterization , product-related impurity characterization, ...
Breaking Biology Technology:
(Date:2/3/2017)... A new independent identity strategy consultancy firm announces its ... to fill a critical niche in technical and policy ... Mark Crego and Janice Kephart together ... that span federal governments, the 9/11 Commission, private industry, ... has a common theme born from a shared passion ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
(Date:1/26/2017)...  Acuity Market Intelligence today released the 2017 ...  Acuity characterizes 2017 as a "breakout" year for ... a new understanding of the potential benefits these ... identity are often perceived as threats to privacy ... of Acuity Market intelligence. "However, taken together these ...
Breaking Biology News(10 mins):